Agilent Q4 Revenues Climb 35 Percent

Its Life Science Group revenues rose 35 percent, helped along by a 31 percent increase in its academic/government business and a 14 percent jump in pharmaceutical/biotech sales.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.